Guru Ownership Trend
Guru Analysis for Recursion Pharmaceuticals, Inc. (RXRX)
Recursion Pharmaceuticals, Inc. (RXRX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2025, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $162.77 M.
Top institutional holders include Catherine Wood and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $2.72 M net inflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 7.3%.
| Portfolio Manager | % Portfolio | Activity | Shares | Value | Report Date |
|---|---|---|---|---|---|
| 0.97% | Add 1.7% | 33,545,499 | $163.7 M | Q3 2025 | |
| 0.00% | Add 7.3% | 14,910 | $72,761 | Q3 2025 |
| Report Date | Portfolio Manager | Activity | Share Change | % Portfolio Change |
|---|
| Report Date | Portfolio Manager | Activity | Share Change | % Portfolio Change |
|---|
| Report Date | Portfolio Manager | Activity | Share Change | % Portfolio Change |
|---|
| Portfolio Manager | Option Type | % Portfolio | Activity | Shares | Value | Report Date |
|---|
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q3 2025)
Guru Consensus (Q3 2025)
FAQs for Recursion Pharmaceuticals, Inc. (RXRX)
Major holders include Catherine Wood ($163.7 M), Cliff Asness ($72,761). According to the latest reported data, 2 tracked investment managers collectively hold approximately 33.56 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $2.72 M, with 2 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in RXRX during the most recent reporting period.
Yes, 0 managers opened new positions in RXRX, and 2 increased their existing holdings. The total reported buy value was $2.72 M.